Pharma Indonesia
Sector: Waste Processing and Treatment • Location: Indonesia
Source: International Finance Corporation (IFC)
BrightGene Bio-Medical Technology Co, Ltd (hereinafter referred to as “Brightgene”) is a leading Chinese biopharmaceutical company that focuses on the Research and Development (R&D) and manufacturing of high barrier generics, Active Pharmaceutical Ingredients (APIs) and Finish Dosage Forms (FDFs). This Shanghai Stock Exchange listed company is headquartered in Suzhou City, Jiangsu Province, with m
- Status
- Prospective
- Sector
- Waste Processing and Treatment, Manufacturing (Industrial), Water Supply and Storage, Hospital, Government, Commercial
- Location
- Indonesia
- Updated
- 22 Jul 2026
- Source
- International Finance Corporation (IFC)
ConstructChat
Ask ConstructChat about Pharma Indonesia
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
Sponsoring Agency |
Status
Original status | active |
Taiyo status | Prospective |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | BrightGene Bio-Medical Technology Co, Ltd (hereinafter referred to as “Brightgene”) is a leading Chinese biopharmaceutical company that focuses on the Research and Development (R&D) and manufacturing of high barrier generics, Active Pharmaceutical Ingredients (APIs) and Finish Dosage Forms (FDFs). This Shanghai Stock Exchange listed company is headquartered in Suzhou City, Jiangsu Province, with manufacturing plants situated in Suzhou, Taizhou and Chongqing. All the plants are compliant with Current Good Manufacturing Practice (CGMPs) which is the main regulatory standard for ensuring pharmaceutical quality under the American Food and Drug Administration. The plants have also received regulatory approvals from relevant organization within the European Union, Japan, Korea and China. Product sales represent BrightGenes primary income stream contributing 85.5% in 2020. IFC is considering a $50 million loan to finance BrightGene’s expansion into Indonesia. Brightgene subsidiary, PT BrightGene Biomedical Indonesia (hereafter referred to as “PT BBI” or “the company”) is situated within the Karawang New Industrial City (KNIC) an industrial park located in Karawang, West Java Province, approximately 50 km south-east of Jakarta, Indonesia. Construction commenced in 2019 and is scheduled to be completed by November 2021, whereafter a trial and commissioning phase will commence. The manufacturing plant is part one of a three phase development plan for the company in Indonesia which comprises of: i) Phase One (funded under this proposed loan) - API development, with focus on manufacturing APIs for antivirus, oncology, cardiovascular and diabetes products); ii) Phase Two - FDF, including FDF from Phase One APIs, Oral FDF and injectables and iii) Phase Three (development of inhalants such as Budesonide and Fluticasone). The manufactured APIs will initially service the Indonesian market; however, the Company plans to also export its products to other markets within South-East Asia as well as Muslim majority countries who prefer Halal certified products. This investment shall focus on Phase One. |
Original sector | other |
Location
Country | Indonesia |
Source
Source | International Finance Corporation (IFC) |
URL |
More Details
Record type | Project |
Sector | Waste Processing and Treatment, Manufacturing (Industrial), Water Supply and Storage, Hospital, Government, Commercial |
Article published date | 2025-08-08 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
More Waste Processing and Treatment projects in Indonesia
- Cirebon CoalFired Power Plant Expansion West Java
- Jatiluhur I Drinking Water Supply System
- Tangerang Water Supply
- Biopolis Biomedical Research Hub, Buona Vista
- West Semarang Drinking Water Supply System
- Bintang Timur recycling sites portfolio expansion
- Medan drinking water production plant
- Medan Water Supply
